Brooke Army Medical Center is the United States Army's premier medical institution. Located on Fort Sam Houston, BAMC, a 425-bed Academic Medical Center, is the Department of Defense's largest facility and only Level 1 Trauma Center.

During the past decade, Brooke Army Medical Center conducted 107 clinical trials. In the 10-year time frame, 107 clinical trials started and 107 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 51 clinical trials were completed. i.e. 118.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brooke Army Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 94 trials, followed by "Brooke Army Medical Center" with 52 trials sponsored, "National Cancer Institute (NCI)" with 35 trials sponsored, "Children's Oncology Group" with 24 trials sponsored and "Celgene" with 24 trials sponsored. Other sponsors include 167 different institutions and companies that sponsored additional 101 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brooke Army Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 168 trials as a collaborator, "SWOG Cancer Research Network" with 22 trials as a collaborator, "Cancer and Leukemia Group B" with 19 trials as a collaborator, "Brooke Army Medical Center" with 14 trials as a collaborator and "Eastern Cooperative Oncology Group" with 13 trials as a collaborator. Other collaborators include 208 different institutions and companies that were collaborators in the rest 137 trials.

According to Clinical.Site data, the most researched conditions in "Brooke Army Medical Center" are "Lung Cancer" (18 trials), "Breast Cancer" (13 trials), "Lymphoma" (11 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (11 trials) and "Leukemia" (10 trials). Many other conditions were trialed in "Brooke Army Medical Center" in a lesser frequency.

Most popular intervention types in "Brooke Army Medical Center" are "Drug" (272 trials), "Other" (99 trials), "Biological" (65 trials), "Procedure" (45 trials) and "Radiation" (40 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (44 trials), "Placebo" (43 trials), "cisplatin" (24 trials), "radiation therapy" (22 trials) and "cyclophosphamide" (20 trials). Other intervention names were less common.

The vast majority of trials in "Brooke Army Medical Center" are 328 trials for "All" genders, 46 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Brooke Army Medical Center". 1 are not yet recruiting, 38 are recruiting, 45 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 232 completed trials in Brooke Army Medical Center, undefined suspended trials, and 40 terminated clinical trials to date.

Out of the total trials that were conducted in Brooke Army Medical Center, 15 "Phase 1" clinical trials were conducted, 115 "Phase 2" clinical trials and 140 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 22 trials, and there were also 64 trials that are defined as “Not Applicable".